Jeanne Shen

Associate Professor

Stanford University
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (15)

To advance precision medicine in pathology, robust AI-driven foundation models are increasingly needed to uncover complex patterns in large-scale pathology datasets, enabling more accurate disease detection, classification, and prognostic insights. However, despite substantial progress in deep learning and computer vision, the comparative performance and generalizability of these pathology foundation models across diverse histopathological datasets and tasks remain largely unexamined. In this study, we conduct a comprehensive benchmarking of 31 AI foundation models for computational pathology, including general vision models (VM), general vision-language models (VLM), pathology-specific vision models (Path-VM), and pathology-specific vision-language models (Path-VLM), evaluated over 41 tasks sourced from TCGA, CPTAC, external benchmarking datasets, and out-of-domain datasets. Our study demonstrates that Virchow2, a pathology foundation model, delivered the highest performance across TCGA, CPTAC, and external tasks, highlighting its effectiveness in diverse histopathological evaluations. We also show that Path-VM outperformed both Path-VLM and VM, securing top rankings across tasks despite lacking a statistically significant edge over vision models. Our findings reveal that model size and data size did not consistently correlate with improved performance in pathology foundation models, challenging assumptions about scaling in histopathological applications. Lastly, our study demonstrates that a fusion model, integrating top-performing foundation models, achieved superior generalization across external tasks and diverse tissues in histopathological analysis. These findings emphasize the need for further research to understand the underlying factors influencing model performance and to develop strategies that enhance the generalizability and robustness of pathology-specific vision foundation models across different tissue types and datasets. PathBench : https://pathbench.stanford.edu/

Year:

2025

Background Biomarkers have limited reliability, making predictions of response to immune checkpoint inhibitors (ICIs) challenging in gastric cancer. We developed and validated an artificial intelligence (AI)-based model using whole slide images (WSIs) to predict ICI response and assess its prognostic and biological relevance. Methods In this multicenter retrospective study, we developed an AI model using a development cohort (internal) consisting of 272 slides from 107 patients and validated it externally on two independent cohorts comprising 373 slides from 127 patients and 25 slides from 18 patients, respectively. Three histopathology foundation models and eight multiple-instance learning algorithms were compared to optimize prediction performance. Spatial transcriptomics (Xenium 5K) data from 14 ICI-treated patients were used to identify spatial biomarkers by differential expression analysis. Gene ontology analysis was performed on transcriptomic data from TCGA-STAD to characterize the genes associated with the predictions of the AI model. Results The combination of the UNI foundation model with the CLAM algorithm achieved the best performance for the internal test cohort (AUROC = 0.844). High-attention patches revealed signet ring cells and fibrosis in non-responders versus nuclear hyperchromasia and enlarged nuclei in responders. The external validation revealed an AUROC of 0.7151 and 0.7545, respectively. Survival analysis revealed a significant association between the internal test cohort and progression-free and overall survival ( p < 0.001), which was also observed in the external cohort ( p < 0.05). Genes associated with AI predictions in TCGA showed immune activation in responders and increased cell cycle activity in non-responders. Spatial transcriptomics confirmed multi-compartmental FGFR2 overexpression in non-responders and strong immune pathway enrichment in responders, particularly in densely infiltrated tumor regions. Conclusion Our results indicate that AI-powered histopathologic slide analysis represents a robust biomarker for predicting immunotherapy response and patient outcomes in gastric cancer. Integration with spatial and bulk transcriptomic data confirms its biological validity, thus supporting AI-guided pathology as a scalable approach for informed immunotherapy in gastric cancer.

Year:

2025

Thus Figure illustrates how macrophage subsets detected using scRNAseq, 4-color IF, and CODEX correspond to each other and shows representative examples of protein marker expression across macrophage niches.

Year:

2024

This Figure shows protein marker expression across different cell types detected in CODEX experiment, macrophage distance to the closest tumor cell, macrophage distribution across different tissue niches, and tissue niche distribution across different anatomical locations.

Year:

2024

This Figure is a visual summary of this work’s findings and shows the spatial distribution of distinct macrophage subsets in the tumor microenvironment and the clinical significance of IL4I1+ and SPP1+ macrophages in breast and colon tumors.

Year:

2024

This Figure shows the spatial interaction of FOLR2+ macrophages with Plasma Cells in normal colon lamina propria, normal breast, normal lymph node, and breast cancer adjacent normal tissue. It also illustrates ligand-receptor interactions predicted to occur between FOLR2+ macrophages and Plasma Cells.

Year:

2024

Thus Figure shows spatial enrichment of NLRP3+ macrophages with neutrophils in Crohn’s Disease, and immunostimulatory and immunosuppressive protein marker expression in NLRP3+ vs SPP1+ macrophages.

Year:

2024

Thus Figure illustrates how macrophage subsets detected using scRNAseq, 4-color IF, and CODEX correspond to each other and shows representative examples of protein marker expression across macrophage niches.

Year:

2024

Tumor-associated macrophages are transcriptionally heterogeneous, but the spatial distribution and cell interactions that shape macrophage tissue roles remain poorly characterized. Here, we spatially resolve five distinct human macrophage populations in normal and malignant human breast and colon tissue and reveal their cellular associations. This spatial map reveals that distinct macrophage populations reside in spatially segregated micro-environmental niches with conserved cellular compositions that are repeated across healthy and diseased tissue. We show that IL4I1 + macrophages phagocytose dying cells in areas with high cell turnover and predict good outcome in colon cancer. In contrast, SPP1 + macrophages are enriched in hypoxic and necrotic tumor regions and portend worse outcome in colon cancer. A subset of FOLR2 + macrophages is embedded in plasma cell niches. NLRP3 + macrophages co-localize with neutrophils and activate an inflammasome in tumors. Our findings indicate that a limited number of unique human macrophage niches function as fundamental building blocks in tissue. Significance: This work broadens our understanding of the distinct roles different macrophage populations may exert on cancer growth and reveals potential predictive markers and macrophage population-specific therapy targets.

Year:

2024

Tumor-associated macrophages are transcriptionally heterogeneous, but the spatial distribution and cell interactions that shape macrophage tissue roles remain poorly characterized. Here, we spatially resolve five distinct human macrophage populations in normal and malignant human breast and colon tissue and reveal their cellular associations. This spatial map reveals that distinct macrophage populations reside in spatially segregated micro-environmental niches with conserved cellular compositions that are repeated across healthy and diseased tissue. We show that IL4I1 + macrophages phagocytose dying cells in areas with high cell turnover and predict good outcome in colon cancer. In contrast, SPP1 + macrophages are enriched in hypoxic and necrotic tumor regions and portend worse outcome in colon cancer. A subset of FOLR2 + macrophages is embedded in plasma cell niches. NLRP3 + macrophages co-localize with neutrophils and activate an inflammasome in tumors. Our findings indicate that a limited number of unique human macrophage niches function as fundamental building blocks in tissue. Significance: This work broadens our understanding of the distinct roles different macrophage populations may exert on cancer growth and reveals potential predictive markers and macrophage population-specific therapy targets.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (14)

Matt van de Rijn

prof

Stanford University

UNITED STATES
View details

Garry Nolan

Professor and Carlota A. Harris Professor

Stanford University School of Medicine

UNITED STATES
View details

Aaron Newman

Associate Professor

Stanford University

UNITED STATES
View details

Guolan Lu

Assistant Professor

Stanford University

UNITED STATES
View details

Ravi Madduri

Senior Scientist

Argonne National Laboratory

UNITED STATES
View details

Robert B. West

Stanford University School of Medicine

UNITED STATES
View details

Jeong Hoon Lee

Stanford University Medical Center

UNITED STATES
View details

Olivier Gevaert

Assistant Professor

Stanford University

UNITED STATES
View details

Yuanning Zheng

Assistant Professor

University of Houston

UNITED STATES
View details

Deana Colburg

Stanford University

UNITED STATES
View details

John Hickey

Assistant Professor

Duke University

UNITED STATES
View details

Myung-Giun Noh

Assistant Professor

Ajou University School of Medicine

SOUTH KOREA
View details

Gregory W Charville

Associate Professor

Stanford University

UNITED STATES
View details

Kyle Loh

Associate Professor and The Anthony DiGenova Endowed Faculty Scholar

Stanford University School of Medicine

UNITED STATES
View details